ARCHIVES

Alimta Reduces Risk Of Progression In Patients Aged 70 Years or Older

This article is from The Cancer Letter archive.

Vol. 34 No. 10 | October 28, 2011

Download PDF Visit The Full Archive

Related Articles

Amgen Takes Its Case for Aranesp To Lawmakers, Patients, Physicians

January 31, 2003

Cancer Control Awards $1 .5 Million Grant For 3-Year Study By College Of Radiology

April 26, 1974

Individualized Cancer Vaccines Show 90% Survival at 6 Months

December 27, 2013

Newell, Fredrickson Question Ethics Of Laetrile Trials

July 22, 1977

ASCO Urges Increase In Research Funding, Removal of Barriers For Trial Participation

January 23, 2009

Dasatinib, Nilotinib Show Strong Early Results As Frontline Therapy For CML

December 28, 2007